Collecting blood samples to develop a colorectal cancer screening test

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PROCEED-CRC study aims to collect blood samples from participants who are at average risk for colorectal cancer. Participants will provide written consent and undergo blood draws, followed by a colonoscopy within 120 days. The collected samples will be utilized for research purposes to develop a blood-based screening assay for early detection of colorectal cancer. Participants will not receive any test results from the blood collection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. 40 years of age or older at time of consent.
2. Planning or intending to undergo asymptomatic screening colonoscopy.
3. Able to tolerate venipuncture for research draw(s).
4. Able and willing to provide blood samples within the 120 days prior to a colonoscopy procedure.
5. Willing and able to comply with the study visit schedule and study requirements.
6. Signed informed consent(s) must be obtained prior to participation in the study

Exclusion Criteria:

1. Any prior history of any kind of malignancy (exception: participants who have undergone surgical removal of skin squamous cell or basal cell cancer may be enrolled provided the procedure was completed at least 12 months prior to the date of provision of informed consent for the study)
2. Had a complete colonoscopy with adequate bowel preparation in the previous nine (9) years.
3. Undergoing diagnostic colonoscopy for investigation of symptoms such as unexplained and long-lasting diarrhea, overt rectal bleeding, e.g., hematochezia or melena, within the previous 30 days. (Blood on toilet paper, after wiping, does not constitute rectal bleeding)
4. Undergone colorectal cancer screening within the associated recommended intervals

   1. FOBT/FIT within the previous 12 months
   2. FIT-DNA test within the previous 36 months
   3. Blood-based CRC screening test within the previous 36 months
   4. Computed tomography colonography CTC within the previous 5 years
   5. Flexible sigmoidoscopy within the previous 5 years
5. Precancerous findings on most recent colonoscopy. This does not include benign, and/or hyperplastic polyps of any size (Note: Tissue biopsies that result in no histopathology findings are acceptable)
6. Had a prior colorectal resection for any reason other than sigmoid diverticular disease
7. Diagnosis or personal history of any of the following high-risk conditions for colorectal cancer:

   1. Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohns disease
   2. Familial adenomatous polyposis (also referred to as FAP, including attenuated FAP)
   3. Hereditary non-polyposis colorectal cancer syndrome (also referred to as HNPCC or Lynch Syndrome)
   4. Other hereditary cancer syndromes including but are not limited to Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Gardners Syndrome, Turcots (or Crails) Syndrome, Cowdens Syndrome, Juvenile Polyposis, Cronkhite-Canada Syndrome, Neurofibromatosis and Familial Hyperplastic Polyposis

Where it's running

• Natera
  Austin, Texas, United States Recruiting

Study contacts

• Study coordinator: Natera PROCEED-CRC Study team
• Email: proceedcrc@natera.com
• Phone: 6504899050

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Electrolyte beverage plus PEG for colonoscopy bowel prep

  This randomized trial tests different mixes of electrolyte drink and water with PEG to see which bowel prep regimen gives the best cleansing for adults getting colonoscopy.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07608120

• Using prior CT scans to guide colonoscope insertion

  This trial will test whether using a patient's existing abdominal/pelvic CT scan to guide colonoscope insertion makes colonoscopy faster and more comfortable for adults having screening or diagnostic colonoscopy.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07541924

• Animated storytelling video to boost colorectal cancer screening

  A short animated video is being tested to see if it makes adults in the U.S. who haven’t been screened more likely to plan getting screened for colorectal cancer.

  Recruiting Stanford University · Stanford, California · NCT07522177

• Does GP endorsement and early information improve colonoscopy follow-up after a positive colorectal cancer screening test?

  This study tests whether giving patients early information about colonoscopy and having their GP endorse the follow-up can increase how many people in France get a colonoscopy within six months after a positive screening result.

  Recruiting Phase 3 University Hospital, Caen · Tours, France · NCT07520578

• Pilot of a colorectal cancer education program

  This program will test whether a culturally and language‑targeted education program helps adults aged 45–75 who are overdue for colorectal cancer screening complete recommended screening.

  Recruiting NYU Langone Health · New York, New York · NCT07361614

• Noninvasive blood miRNA test to screen for multiple gastrointestinal cancers.

  This project will test whether a blood-based microRNA panel can detect several types of gastrointestinal cancer in adults using stored blood samples.

  Recruiting City of Hope Medical Center · Duarte, California · NCT07224750

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.